Huagai Capital
华盖资本
Huagai Capital is a Chinese venture capital firm with a track record in both healthcare and hard-tech investments. It co-led the angel round of Index Technology in 2024 alongside Qifu Capital, backing the AI hardware-design startup when it was still at the demo stage . In healthcare, it has been a repeat backer of Shukun Technology, participating in its 590 million yuan round in late 2020 and again in a 700 million yuan round in mid-2021 , and joined the Series C of QLT Biotherapeutics in early 2026 . The firm tends to invest across stages and to follow on in portfolio companies.
AI-generated — may contain errors, please verify.
Coverage
5Y News | QLT Biotherapeutics Raises Over 500 Million RMB in Series C Funding
Zhitai Biotech Closes Over 500 Million Yuan Series C Round to Accelerate Core Clinical Pipeline Development
BlueRun Ventures Continues to Double Down as QLT Biotherapeutics Closes Over RMB 500 Million Series C Round | BlueRun Family
Accelerate core clinical pipeline development
Yunqi Capital Leads Index Technology's Nearly RMB 100 Million Pre-A Round: Hardware Design Enters Its "Vibe Coding" Moment | Yunqi Capital
What's Happening with AI for Hardware?
An AI Company That Wants Ordinary People to "Hard Control" Shenzhen's Electronics Hub Raises Nearly 100 Million Yuan
Another kind of equality.
Embodied Intelligence, Pet Medicine, Brain Science, Gene Therapy... 6 Companies Announce New Funding Rounds | FreeS Family Funding News Vol.23
Looking forward to working alongside more outstanding founders.
Qitan Tech Closes RMB 700 Million Series C Round to Advance Commercialization of Domestic Nanopore Sequencing Technology
Breaking Through the "Mass-Production No-Man's-Land" of Domestic Nanopore Sequencing
5Y Capital Portfolio Company Shukun Technology Announces New 700 Million Yuan Funding Round | 5Y News
Digital human platforms are penetrating deep into healthcare scenarios.
5Y News | Shukun Technology Secures Another 590 Million Yuan in Funding, 5Y Capital Continues Its Support
Shukun Technology Raises Another 590 Million Yuan in Funding, Accelerating Medical AI Value Realization with Triple-Class Certification and Capital Backing
